| Jacqlyn E Long, OD | |
|
211 E Broadway, Alton, IL 62002-6220 | |
| (618) 462-9818 | |
| (314) 741-4947 |
| Full Name | Jacqlyn E Long |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 35 Years |
| Location | 211 E Broadway, Alton, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992866057 | NPI | - | NPPES |
| 0854830001 | Other | DMERC | |
| 318096041 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | T02865 (Missouri) | Secondary |
| 152W00000X | Optometrist | 046-008207 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nucrown, Llc | 1456256346 | 21 |
| Nucrown, Llc | 1456256346 | 21 |
News Archive
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.
Experts at the University of Pittsburgh School of Medicine are leading the second arm of a clinical trial using gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson's disease.
› Verified 6 days ago
| Provider Name | Nucrown, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1295737294 PECOS PAC ID: 1456256346 Enrollment ID: O20041025000051 |
News Archive
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.
Experts at the University of Pittsburgh School of Medicine are leading the second arm of a clinical trial using gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacqlyn E Long, OD 8885 Ladue Rd, Saint Louis, MO 63124-2088 Ph: (314) 721-2720 | Jacqlyn E Long, OD 211 E Broadway, Alton, IL 62002-6220 Ph: (618) 462-9818 |
News Archive
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing solutions to the life sciences industries, announce today that they have received French Government funding through OSEO to finance the development of CER-001, a Cerenis HDL mimetic.
In the June 13 issue of Science Translational Medicine, an international team led by researchers from the University of California, San Diego School of Medicine reports that the new technology of exome sequencing is not only a promising method for identifying disease-causing genes, but may also improve diagnoses and guide individual patient care.
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
ContextVision is pleased to a announce that today at the ECR in Vienna, it is officially launching the first product stemming from its recently announced strategic alliance with NeuSoft Medical Technologies.
Experts at the University of Pittsburgh School of Medicine are leading the second arm of a clinical trial using gene therapy to relieve the symptoms of tremor and mobility impairment in patients with Parkinson's disease.
› Verified 6 days ago
Aeg Delaware Professional Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 | |
Aeg Connecticut Professional Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947 | |
Dr. James Walter Lieber, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 401 Henry St, Alton, IL 62002 Phone: 618-465-6000 | |
Mark D. Wade O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947 | |
Crown Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 111 E 4th St Ste 440, Alton, IL 62002 Phone: 618-462-9818 Fax: 314-741-4947 | |
Clarkson Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1819 Homer Adams Parkway, Suite B, Alton, IL 62002 Phone: 636-200-4393 Fax: 636-938-2650 | |
Pearle Vision Of Alton, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2865 Homer M Adams Pkwy, Alton, IL 62002 Phone: 618-465-1654 Fax: 618-465-8652 |